Steven L. Hoerter insider trades: MBX Biosciences (MBX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
and 3 more companies
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | MBX | ↑ Buy | 20,000 | $13.25 | $265K | By Trust | Oct 20, 2025 (3d) |
| Dec 13, 2023 | DCPH | ↓ Sell | 30,664 | $15.37 | $471K | Direct | Dec 14, 2023 (1d) |
| Oct 30, 2023 | DCPH | ↓ Sell | 21,573 | $12.02 | $259K | Direct | Oct 31, 2023 (1d) |
| Mar 21, 2023 | DCPH | ↓ Sell | 7,500 | $15.57 | $117K | Direct | Mar 23, 2023 (2d) |
| Feb 14, 2023 | DCPH | ↓ Sell | 30,045 | $16.00 | $481K | Direct | Feb 16, 2023 (2d) |
| Mar 4, 2019 | AGIO | ↓ Sell | 10,000 | $67.00 | $670K | Direct | Mar 5, 2019 (1d) |
| Aug 24, 2018 | AGIO | ↓ Sell | 2,050 | $74.92 | $154K | Direct | Aug 28, 2018 (4d) |
| Jul 25, 2018 | AGIO | ↓ Sell | 2,050 | $84.58 | $173K | Direct | Jul 27, 2018 (2d) |
| Jun 22, 2018 | AGIO | ↓ Sell | 2,050 | $97.58 | $200K | Direct | Jun 26, 2018 (4d) |
| May 23, 2018 | AGIO | ↓ Sell | 2,050 | $85.76 | $176K | Direct | May 29, 2018 (6d) |
| Apr 23, 2018 | AGIO | ↓ Sell | 2,050 | $85.95 | $176K | Direct | Apr 25, 2018 (2d) |
| Mar 22, 2018 | AGIO | ↓ Sell | 2,050 | $84.65 | $174K | Direct | Mar 26, 2018 (4d) |
| Feb 22, 2018 | AGIO | ↓ Sell | 2,050 | $78.63 | $161K | Direct | Feb 26, 2018 (4d) |
| Jan 23, 2018 | AGIO | ↓ Sell | 25,000 | $74.83 | $1.9M | Direct | Jan 25, 2018 (2d) |
| Mar 5, 2015 | CLVS | ↓ Sell | 20,000 | $80.00 | $1.6M | Direct | Mar 9, 2015 (4d) |
| Feb 17, 2015 | CLVS | ↓ Sell | 10,000 | $72.00 | $720K | Direct | Feb 19, 2015 (2d) |
| Jan 16, 2015 | CLVS | ↓ Sell | 10,000 | $67.00 | $670K | Direct | Jan 20, 2015 (4d) |
| Jan 13, 2015 | CLVS | ↓ Sell | 10,000 | $62.00 | $620K | Direct | Jan 15, 2015 (2d) |
| Jun 4, 2013 | CLVS | ↓ Sell | 10,000 | $73.06 | $731K | Direct | Jun 6, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MBX insiders
Open-market trades in the last 12 months
About Steven L. Hoerter's insider trades
Steven L. Hoerter is President and CEO at MBX Biosciences (MBX). Since Jun 4, 2013, Steven has reported 1 open-market purchase worth $265K and 18 sales worth $9.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (46 filings), option exercises (23 filings), shares withheld for taxes (5 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.